Viewing Study NCT02869295


Ignite Creation Date: 2025-12-24 @ 2:19 PM
Ignite Modification Date: 2026-01-13 @ 9:37 PM
Study NCT ID: NCT02869295
Status: COMPLETED
Last Update Posted: 2021-07-29
First Post: 2016-08-03
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
Sponsor: Nektar Therapeutics
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 15-214-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators